Matti Zemack joins Industrifonden as Investment Director

CEO change at Industrifonden

Exeri closes a €5 m funding round, led by Industrifonden

OxThera Raises EUR 32 Million to Complete Development of Oxabact® for Treatment of Primary Hyperoxaluria

Scandinavian Life Science Funding Report 2014–2016

Now Interact secures $5M Series A Round from Industrifonden, SEB and Inventure

BONESUPPORT raises $37 million to deliver further value from CERAMENT platform

Industrifonden Leads $6M Series A Round in Soundtrap

Nuevolution Announces Strategic Collaboration with Amgen in Oncology and Neuroscience